期刊信息

  • 刊名: 河北师范大学学报(自然科学版)Journal of Hebei Normal University (Natural Science)
  • 主办: 河北师范大学
  • ISSN: 1000-5854
  • CN: 13-1061/N
  • 中国科技核心期刊
  • 中国期刊方阵入选期刊
  • 中国高校优秀科技期刊
  • 华北优秀期刊
  • 河北省优秀科技期刊

含苯并咪唑环N-酰腙衍生物的合成及作为Cdc25B和PTP1B抑制剂的生物评价

  • 1. 辽宁师范大学 化学化工学院, 辽宁 大连 116029;
    2. 中国科学院 上海药物研究所, 国家新药筛选中心, 药物研究国家重点实验室, 上海 201203;
    3. 大连理工大学 精细化工国家重点实验室, 辽宁 大连 116012
  • DOI: 10.13763/j.cnki.jhebnu.nse.2017.02.009

Synthesis and Biological Evaluation of N-acylhydrazone Derivatives Containing Benzimidazole Moiety as Cdc25B and PTP1B Inhibitors

摘要/Abstract

摘要:

以酚和氯乙酸为起始原料,经多步反应,合成出了14个新型的含苯并咪唑环N-酰腙衍生物5a~5n,并利用IR,1HNMR和元素分析确定了其结构.评价了目标化合物对Cdc25B和PTP1B的抑制活性,讨论了结构与活性的关系.实验结果表明,大部分化合物对PTP1B显示出良好的抑制活性[IC50=(6.43±0.88)~(19.76±4.00)μg/mL],其中5h的抑制活性最高[IC50=(6.43±0.88)μg/mL].目标化合物5a~5n对Cdc25B有弱的抑制活性.

Abstract:

Fourteen New N-acylhydrazone derivatives containing benzimidazole moiety (5a~5n) were synthesized by substituted phenol and chloroacetic acid as starting materials via multistep reactions. Their structures were confirmed by elemental analysis, IR and 1H NMR spectra. The synthesized target compounds 5 were evaluated for the inhibitory activities against Cdc25B and PTP1B. The structure-activity relationship was also discussed. The experimental results showed that most compounds exhibited good inhibitory activities against PTP1B [IC50=(6.43 ± 0.88)~(19.76 ± 4.00) μg/mL]. Among of them, compound 5h exhibited highest inhibitory activity [IC50=(6.43 ± 0.88) μg/mL]. The target compounds 5a~5n had weak inhibitory activity for Cdc25B.

参考文献 19

  • [1] ZHANG L,JIANG C S, GAO L X,et al. Design,synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity[J]. Bioorg Med Chem Lett, 2016,26(3):778-781. doi:10.1016/j.bmcl.2015.12.097
  • [2] ROSENKER K M G,PAQUETTE W D, JOHNSTON P A,et al. Synthesis and biological evaluation of 3-aminoisoquinolin-1(2H):one based inhibitors of the dual-specificity phosphatase Cdc25B[J]. Bioorg Med Chem,2015,23(12):2810-2818.doi:10.1016/j.bmc.2015.01.043
  • [3] LI Y J,YU Y,JIN K,et al.Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors[J]. Bioorg Med Chem Lett,2014,24(17): 4125-4128. doi:10.1016/j.bmcl.2014.07.055
  • [4] DANIEL A R,GUILHERME A F S,ANA C S F. Design,Synthesis, and Pharmacological Evaluation of Novel N-acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors[J].J Med Chem,2016,59(2): 655-670. doi:10.1021/acs.jmedchem.5b01525
  • [5] YU X F, SHI L Q, KE S Y. Acylhydrazone Derivatives as Potential Anticancer Agents: Synthesis, Bio-evaluation and Mechanism of Action[J]. Bioorg Med Chem Lett, 2015, 25(24): 5772-5776.doi: 10.1016/j.bmcl.2015.10.069
  • [6] BOUHADIR K H, KOUBEISSI A, MOHSEN F A,et al. Novel Carbocyclic Nucleoside Analogs Suppress Glomerular Mesangial Cells Proliferation and Matrix Protein Accumulation Through ROS-dependent Mechanism in the Diabetic Milieu Ⅱ:Acylhydrazonefunctionalized Pyrimidines[J]. Bioorg Med Chem Lett,2016,26(3):1020-1024.doi:10.1016/j.bmcl.2015.12.042
  • [7] SATHLER P C,LOURENçO A L L,RODRIGUES C R,et al. In Vitro and in Vivo Analysis of the Antithrombotic and Toxicological Profile of New Antiplatelets N-acylhydrazone Derivatives and Development of Nanosystems[J].Thromb Res,2014, 134(2):376-383.doi:10.1016/j.thromres.2014.05.009
  • [8] TIAN B H, HE M Z,TANG S X,et al. Synthesis and Antiviral Activities of Novel Acylhydrazone Derivatives Targeting HIV-1 Capsid Protein[J]. Bioorg Med Chem Lett,2009,19(8):2162-2167. doi:10.1016/j.bmcl.2009.02.116
  • [9] HERNáNDEZ P, CABRERA M, LAVAGGI M L,et al. Discovery of New Orally Effective Analgesic and Anti-inflammatory Hybrid Furoxanyl N-acylhydrazone Derivatives[J]. Bioorg Med Chem,2012,20(6):2158-2171.doi:10.1016/j.bmc.2012.01.034
  • [10] TAN O U, OZADALI K, YOGEESWARI P, et al.Synthesis and Antimycobacterial Activities of Some New N-acylhydrazone and Thiosemicarbazide Derivatives of 6-methyl-4,5-dihydropyridazin-3(2H)-one[J].Med Chem Res,2012,21(7):2388-2394.doi:10.1007/s00044-011-9770-6
  • [11] YONEDA J D,ALBUQUERQUE M G,LEAL K Z.Docking of Anti-HIV-1 Oxoquinoline-acylhydrazone Derivatives as Potential HSV-1 DNA Polymerase Inhibitors[J]. J Mol Struct, 2014,1074(25):263-270. doi:10.1016/j.molstruc.2014.05.081
  • [12] YADAV G,GANGULY S. Structure Activity Relationship (SAR) Study of Benzimidazole Scaffold for Different Biological Activities:A Mini-review[J]. Eur J Med Chem,2015,97(5):419-443. doi:10.1016/j.ejmech.2014.11.053
  • [13] 李英俊,史相玲,高立信,等.3,5,6-三取代-1,2,4-三嗪衍生物合成、表征及生物活性[J]. 有机化学,2015,35:191-199.doi: 10.6023/cjoc201405032
  • [14] 李英俊,邵昕,李丽娜,等.含苯并咪唑环的-1,3,4-噁二唑衍生物的合成及表征[J]. 河北师范大学学报(自然科学版),2014, 38(1):55-58. doi:10.11826/j.issn.1000-5854.2014.01.012
  • [15] HUANG W G,JIANG Y Y,LI Q,et al. Synthesis and Biological Evaluation of (G)-cryptotanshinone and Its Simplified Analogues as Potent CDC25 Inhibitors[J].Tetrahedron,2005,61(7):1863-1870.doi:10.1016/j.tet.2004.12.033
  • [16] SUN L P,SHEN Q,PIAO H H,et al.Synthesis and Biological Evaluation of (±)-3-(2-(2-fluorobenzyloxy) Naphthalen-6-yl)-2-aminopropanoic Acid Derivatives as Novel PTP1B Inhibitors[J].Eur J Med Chem,2011,46(9):3630-3638.doi:10.1016/j.ejmech.2011.05.027
  • [17] ZHOU M Q,EUN Y J,GUZEI I A,et al.Structure-activity Studies of Divin:An Inhibitor of Bacterial Cell Division[J]. Med Chem Lett, 2013,4(9): 880-885.doi:10.1021/ml400234x
  • [18] KAHVECI B,YıLMAZ F,MENTEşE E,et al.Microwave-assisted Synthesis of Some Novel Benzimidazole Derivatives Containing Imine Function and Evaluation Oftheir Antimicrobial Activity[J].J Heterocycl Chem,2014,51(2):982-990.doi:10.1002/jhet.1593
  • [19] BAYRAK H, DEMIRBAS A,KARAOGLU S A,et al. Synthesis of Some New 1,2,4-triazoles,Their Mannich and Schiff Bases and Evaluation of Their Antimicrobial Activities[J]. Eur J Med Chem,2009,44(3):1057-1066. doi:10.1016/j.ejmech.2008.06.019